Therefore, the aim of the present study was to evaluate PD-L1 expression and its effect on the prognosis and the relationship with clinicopathologic data in patients with non-small cell lung carcinoma (NSCLC). This evidence concerns the gene CD274 and non-small cell lung carcinoma.